Saturday, October 31, 2026

Aphria Stock Is 3% Down So Far Today

ViaNews Editorial Team

December 17, 2020

Aphria Stock Is 3% Down So Far Today

Shares of Aphria dropped 3.6% to $7.76 at 11:52 EST on Thursday, following yesterday's downward trend. The Nasdaq Stock Market is jumping 0.54% to $12,727.00, after three consecutive sessions in a row of gains. This seems, as yet, a somewhat positive trend trading session today.

Aphria's last close was $8.05, 14.43% under its 52-week high of $8.88.

Aphria's Stock Yearly Top and Bottom Value

Aphria's stock is valued at $7.76 at 11:52 EST, way below its 52-week high of $8.88 and way above its 52-week low of $1.95.

Aphria's Moving Average

Aphria's worth is way above its 50-day moving average of $6.62 and way higher than its 200-day moving average of $5.18.

Previous days news about Aphria

Aphria, tilray announce deal to create biggest cannabis company. According to Bloomberg Quint on Wed Dec 16, "A new giant in the fast-growing cannabis industry will be created after Tilray Inc. and Aphria Inc. agreed to combine their operations.", "Through Tuesday's close, Tilray shares have fallen 54% in 2020, while Aphria's have risen 56%."

Tilray stock soars after 'reverse' merger deal with Aphria at a 23% premium. According to MarketWatch on Wed Dec 16, "Shares of Tilray Inc. soared 30.8% in premarket trading and Aphria Inc.'s U.S.-listed stock surged 9.9%, after the Canada-based cannabis companies announced a merger, which they say will create the largest global cannabis company, with a combined equity value of about $3.9 billion. ", "After the deal closes, which the companies said was structured has a "reverse acquisition" of Tilray, Aphria shareholders will own 62% of outstanding Tilray shares. "

Stocks making the biggest moves in the premarket: tilray, Aphria, penumbra, Moderna & more. According to CNBC on Wed Dec 16, "Tilray (TLRY), Aphria (APHA) - The Canadian cannabis companies will combine in an all-stock deal that will create the world's biggest cannabis producer. ", "Tilray shares surged 30%, while Aphria shares jumped more than 8% in the premarket."

Aphria and tilray to merge to create biggest global cannabis company. According to The Wall Street Journal on Wed Dec 16, "Aphria Inc. and Tilray Inc. said Wednesday their proposed combination would create a company with annual revenue on a pro-forma basis of Canadian $874 million, equivalent to $686 million. ", "The deal between Aphria and Tilray could signal more mergers and acquisitions ahead across the industry, according to some analysts. "

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com